870263-72-2

Basic information

• Product Name: 1-Piperidinecarboxylic acid, 4-[(aminocarbonyl)(3,3-diethoxypropyl)amino]-, phenylmethyl ester
• CAS NO: 870263-72-2
• Molecular Formula: C21H33N3O5
• Molecular Weight: 407.51
• Mol File: 870263-72-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-Piperidinecarboxylic acid, 4-[(aminocarbonyl)(3,3-diethoxypropyl)amino]-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 4-[(aminocarbonyl)(3,3-diethoxypropyl)amino]-, phenylmethyl ester(870263-72-2)
• EPA Substance Registry System: 1-Piperidinecarboxylic acid, 4-[(aminocarbonyl)(3,3-diethoxypropyl)amino]-, phenylmethyl ester(870263-72-2)

Safety Data

• Hazardous Substances Data: 870263-72-2(Hazardous Substances Data)

Upstream product

• 590-28-3 potassium cyanate 
• 41365-75-7 aminopropane diethyl acetal 
• 19099-93-5 benzyl 4-oxo-1-piperidinecarboxylate 

Relevant articles and documents

CYCLIC AMIDE DERIVATIVES, AND THEIR PRODUCTION AND USE AS ANTITHROMBOTIC AGENTS

The present invention provides a cyclic amide derivative useful as a drug for treating thrombosis, which is represented by the formula (I): wherein R1 represents an optionally substituted cyclic hydrocarbon group or an optionally substituted heterocyclic group, W represents a bond or an optionally substituted divalent chain hydrocarbon group, a represents 0, 1, or 2, X1 represents an optionally substituted lower alkylene or an optionally substituted lower alkenylene, Y1 represents -C(O)-, -S(O)- or -S(O)2-, A represents a piperazine ring which may be further substituted or a piperidine ring which may be further substituted, X2 represents a bond or an optionally substituted lower alkylene, Y2 represents -C(O)-, -S(O)-, -S(O)2- or -C(=NR7)-, X3 represents an optionally substituted C1-4 alkylene or an optionally substituted C2-4 alkenylene, Z3 represents -N(R4)-, -O- or a bond, Z1 represents -C(R2)(R2')-, -N(R2)-, etc., and Z2 represents -C(R3)(R3')-, -N(R3)-, etc., or a salt thereof.